News
CT is your last chance to file a claim with 23andMe for a 2023 data breach that may have compromised your genetic data.
Regeneron's bid to acquire the bankrupt genetic testing firm 23andMe for $256 million has likely come to an end.
A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...
15don MSN
Anne Wojcicki's nonprofit TTAM Research Institute will purchase "substantially all" of San Francisco-based 23andMe's assets.
Genetic testing company 23andMe can proceed with a $305 million sale to the company’s co-founder Anne Wojcicki after a U.S.
The DNA data of millions of people who used 23andMe's services won't be sold to a pharmaceutical company. A bankruptcy judge ...
16d
Medical Device Network on MSNFormer 23andMe CEO regains company control as $305m sale to nonprofit approvedA court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Regeneron Pharmaceuticals (REGN) exits buyout race for 23andMe as Anne Wojcicki's TTAM Research offers a superior $305M bid. Read more here.
A bankruptcy court gave the green light for TTAM Research Institute - a firm launched by 23andMe's co-founder and former CEO ...
One group of people may receive up to $1,500, and much sooner than they think. There is a catch: only some may qualify for ...
A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe’s co-founder ...
States with privacy objections to the sale have until July 7 to reach a stay to appeal the case. TTAM, a nonprofit started by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results